Literature DB >> 16937289

Long-term survival after salvage resection of recurrent esophageal cancer with anterior mediastinal lymph node involvement: report of a case.

Satoru Motoyama1, Reijiro Saito, Manabu Okuyama, Kiyotomi Maruyama, Hiroshi Nanjo, Jun-Ichi Ogawa.   

Abstract

A 55-year-old man underwent subtotal esophagectomy with extended three-field lymph node dissection for squamous cell carcinoma of the middle thoracic esophagus (histological stage pT3N4(3b)M0, pStage IVa). About 9 months later, contrast-enhanced computed tomography showed recurrence in several lymph nodes in the anterior mediastinum and the right side of the neck. We treated the recurrence by dissecting the affected nodes, followed by chemoradiotherapy. At the time of writing, 5 years later, the patient was well, without any further evidence of recurrence. Although the indications for resection of recurrent esophageal cancer are controversial and we cannot generalize about the best treatment for these patients, this case highlights the possibility of using salvage surgical resection to treat recurrent esophageal cancer with anterior mediastinal lymph node involvement in selected patients.

Entities:  

Mesh:

Year:  2006        PMID: 16937289     DOI: 10.1007/s00595-006-3242-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagus.

Authors:  S Abo; M Kitamura; M Hashimoto; K Izumi; Y Minamiya; T Shikama; H Suzuki; K Temma; S Kamata; R Saito
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Localization of recurrent disease after extended lymph node dissection for carcinoma of the thoracic esophagus.

Authors:  T Matsubara; M Ueda; T Takahashi; T Nakajima; M Nishi
Journal:  J Am Coll Surg       Date:  1996-04       Impact factor: 6.113

4.  Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck.

Authors:  Satoru Motoyama; Michihiko Kitamura; Reijiro Saito; Kiyotomi Maruyama; Manabu Okuyama; Jun-ichi Ogawa
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

5.  Treatment response and prognosis of patients after recurrence of esophageal cancer.

Authors:  Hideaki Shimada; Hiroyuki Kitabayashi; Yoshihiro Nabeya; Shin-ichi Okazumi; Hisahiro Matsubara; Yutaka Funami; Yukimasa Miyazawa; Tooru Shiratori; Takashi Uno; Hisao Itoh; Takenori Ochiai
Journal:  Surgery       Date:  2003-01       Impact factor: 3.982

  5 in total
  3 in total

1.  Superdrainage of the ileocolic vein to the internal jugular vein interposed by an inferior mesenteric vein graft in replacing the esophagus with the right hemicolon.

Authors:  Hideaki Uchiyama; Masaru Morita; Yasushi Toh; Hiroshi Saeki; Yoshihiro Kakeji; Hiroshi Matsuura; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

2.  Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy.

Authors:  Long Sun; Xin-Hui Su; Yong-Song Guan; Wei-Ming Pan; Zuo-Ming Luo; Ji-Hong Wei; Long Zhao; Hua Wu
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

3.  Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.

Authors:  K Parry; E Visser; P S N van Rossum; N Haj Mohammad; J P Ruurda; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2015-09-03       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.